Latest Treatments Ivermectin as an Adjuvant to Immunotherapy in Triple-Negative Breast Cancer Optimization of ivermectin as an adjuvant in TNBC immunotherapy may unlock new therapeutic avenues, but what challenges lie ahead in its implementation? Cancer Terapia TeamJuly 30, 2025 View Post